1. Home
  2. AIN vs OGN Comparison

AIN vs OGN Comparison

Compare AIN & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albany International Corporation

AIN

Albany International Corporation

HOLD

Current Price

$56.79

Market Cap

1.5B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$8.32

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIN
OGN
Founded
1895
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
AIN
OGN
Price
$56.79
$8.32
Analyst Decision
Hold
Hold
Analyst Count
4
5
Target Price
$60.25
$14.10
AVG Volume (30 Days)
286.8K
6.8M
Earning Date
02-25-2026
02-12-2026
Dividend Yield
1.99%
1.00%
EPS Growth
N/A
N/A
EPS
N/A
1.91
Revenue
$1,148,512,000.00
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.18
Revenue Growth
N/A
N/A
52 Week Low
$41.15
$6.18
52 Week High
$83.65
$17.23

Technical Indicators

Market Signals
Indicator
AIN
OGN
Relative Strength Index (RSI) 55.23 48.77
Support Level $54.61 $7.99
Resistance Level $57.21 $8.53
Average True Range (ATR) 1.52 0.45
MACD -0.35 -0.16
Stochastic Oscillator 38.36 17.14

Price Performance

Historical Comparison
AIN
OGN

About AIN Albany International Corporation

Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: